A citation-based method for searching scientific literature

E Ryberg, N Larsson, S Sjögren, S Hjorth, N-O Hermansson, J Leonova, T Elebring, K Nilsson, T Drmota, P J Greasley. Br J Pharmacol 2007
Times Cited: 1059







List of co-cited articles
1643 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor.
R B Laprairie, A M Bagher, M E M Kelly, E M Denovan-Wright. Br J Pharmacol 2015
521
25



International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.
R G Pertwee, A C Howlett, M E Abood, S P H Alexander, V Di Marzo, M R Elphick, P J Greasley, H S Hansen, G Kunos, K Mackie,[...]. Pharmacol Rev 2010
22

GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current.
Jane E Lauckner, Jill B Jensen, Huei-Ying Chen, Hui-Chen Lu, Bertil Hille, Ken Mackie. Proc Natl Acad Sci U S A 2008
463
22

Structure of a cannabinoid receptor and functional expression of the cloned cDNA.
L A Matsuda, S J Lolait, M J Brownstein, A C Young, T I Bonner. Nature 1990
19

Isolation and structure of a brain constituent that binds to the cannabinoid receptor.
W A Devane, L Hanus, A Breuer, R G Pertwee, L A Stevenson, G Griffin, D Gibson, A Mandelbaum, A Etinger, R Mechoulam. Science 1992
19

Agonistic properties of cannabidiol at 5-HT1a receptors.
Ethan B Russo, Andrea Burnett, Brian Hall, Keith K Parker. Neurochem Res 2005
487
18

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors.
A C Howlett, F Barth, T I Bonner, G Cabral, P Casellas, W A Devane, C C Felder, M Herkenham, K Mackie, B R Martin,[...]. Pharmacol Rev 2002
18

Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.
T Bisogno, L Hanus, L De Petrocellis, S Tchilibon, D E Ponde, I Brandi, A S Moriello, J B Davis, R Mechoulam, V Di Marzo. Br J Pharmacol 2001
731
16

Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.
Luciano De Petrocellis, Alessia Ligresti, Aniello Schiano Moriello, Marco Allarà, Tiziana Bisogno, Stefania Petrosino, Colin G Stott, Vincenzo Di Marzo. Br J Pharmacol 2011
508
14

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.
R Mechoulam, S Ben-Shabat, L Hanus, M Ligumsky, N E Kaminski, A R Schatz, A Gopher, S Almog, B R Martin, D R Compton. Biochem Pharmacol 1995
13

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia.
F M Leweke, D Piomelli, F Pahlisch, D Muhl, C W Gerth, C Hoyer, J Klosterkötter, M Hellmich, D Koethe. Transl Psychiatry 2012
566
13

Identification of GPR55 as a lysophosphatidylinositol receptor.
Saori Oka, Keisuke Nakajima, Atsushi Yamashita, Seishi Kishimoto, Takayuki Sugiura. Biochem Biophys Res Commun 2007
317
13

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain.
T Sugiura, S Kondo, A Sukagawa, S Nakane, A Shinoda, K Itoh, A Yamashita, K Waku. Biochem Biophys Res Commun 1995
12

Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome.
Joshua S Kaplan, Nephi Stella, William A Catterall, Ruth E Westenbroek. Proc Natl Acad Sci U S A 2017
194
11

Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide.
P M Zygmunt, J Petersson, D A Andersson, H Chuang, M Sørgård, V Di Marzo, D Julius, E D Högestätt. Nature 1999
11

Identification and functional characterization of brainstem cannabinoid CB2 receptors.
Marja D Van Sickle, Marnie Duncan, Philip J Kingsley, Abdeslam Mouihate, Paolo Urbani, Ken Mackie, Nephi Stella, Alexandros Makriyannis, Daniele Piomelli, Joseph S Davison,[...]. Science 2005
11

Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review.
John M McPartland, Marnie Duncan, Vincenzo Di Marzo, Roger G Pertwee. Br J Pharmacol 2015
301
10

Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
Orrin Devinsky, Maria Roberta Cilio, Helen Cross, Javier Fernandez-Ruiz, Jacqueline French, Charlotte Hill, Russell Katz, Vincenzo Di Marzo, Didier Jutras-Aswad, William George Notcutt,[...]. Epilepsia 2014
499
10

Molecular Targets of Cannabidiol in Neurological Disorders.
Clementino Ibeas Bih, Tong Chen, Alistair V W Nunn, Michaël Bazelot, Mark Dallas, Benjamin J Whalley. Neurotherapeutics 2015
285
10

Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors.
Markus Kathmann, Karsten Flau, Agnes Redmer, Christian Tränkle, Eberhard Schlicker. Naunyn Schmiedebergs Arch Pharmacol 2006
209
10

CB2: a cannabinoid receptor with an identity crisis.
Brady K Atwood, Ken Mackie. Br J Pharmacol 2010
417
10


Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro.
A Thomas, G L Baillie, A M Phillips, R K Razdan, R A Ross, R G Pertwee. Br J Pharmacol 2007
461
10


Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain.
M Sawzdargo, T Nguyen, D K Lee, K R Lynch, R Cheng, H H Heng, S R George, B F O'Dowd. Brain Res Mol Brain Res 1999
254
10

Antioxidative and Anti-Inflammatory Properties of Cannabidiol.
Sinemyiz Atalay, Iwona Jarocka-Karpowicz, Elzbieta Skrzydlewska. Antioxidants (Basel) 2019
181
9

GPR55: A therapeutic target for Parkinson's disease?
Marta Celorrio, Estefanía Rojo-Bustamante, Diana Fernández-Suárez, Elena Sáez, Ander Estella-Hermoso de Mendoza, Christa E Müller, María J Ramírez, Julen Oyarzábal, Rafael Franco, María S Aymerich. Neuropharmacology 2017
49
18

The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo.
Lauren S Whyte, Erik Ryberg, Natalie A Sims, Susan A Ridge, Ken Mackie, Peter J Greasley, Ruth A Ross, Michael J Rogers. Proc Natl Acad Sci U S A 2009
215
9

The molecular logic of endocannabinoid signalling.
Daniele Piomelli. Nat Rev Neurosci 2003
9


Determination and characterization of a cannabinoid receptor in rat brain.
W A Devane, F A Dysarz, M R Johnson, L S Melvin, A C Howlett. Mol Pharmacol 1988
8



Cannabinoid Ligands Targeting TRP Channels.
Chanté Muller, Paula Morales, Patricia H Reggio. Front Mol Neurosci 2019
223
8

The endocannabinoid system and the brain.
Raphael Mechoulam, Linda A Parker. Annu Rev Psychol 2013
576
8

Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8.
Luciano De Petrocellis, Vittorio Vellani, Aniello Schiano-Moriello, Pietro Marini, Pier Cosimo Magherini, Pierangelo Orlando, Vincenzo Di Marzo. J Pharmacol Exp Ther 2008
221
8

Advances in the Physiology of GPR55 in the Central Nervous System.
Bruno A Marichal-Cancino, Alfonso Fajardo-Valdez, Alejandra E Ruiz-Contreras, Monica Mendez-Díaz, Oscar Prospero-García. Curr Neuropharmacol 2017
57
14

Differential changes in GPR55 during microglial cell activation.
Maciej Pietr, Ewa Kozela, Rivka Levy, Neta Rimmerman, Yi Hsing Lin, Nephi Stella, Zvi Vogel, Ana Juknat. FEBS Lett 2009
92
8

Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses.
Sergiy Sylantyev, Thomas P Jensen, Ruth A Ross, Dmitri A Rusakov. Proc Natl Acad Sci U S A 2013
130
8

Molecular Targets of the Phytocannabinoids: A Complex Picture.
Paula Morales, Dow P Hurst, Patricia H Reggio. Prog Chem Org Nat Prod 2017
205
8

Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55.
Christopher M Henstridge, Nariman A B Balenga, Julia Kargl, Clara Andradas, Andrew J Brown, Andrew Irving, Cristina Sanchez, Maria Waldhoer. Mol Endocrinol 2011
110
8

Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes.
Arkaitz Carracedo, Meritxell Gironella, Mar Lorente, Stephane Garcia, Manuel Guzmán, Guillermo Velasco, Juan L Iovanna. Cancer Res 2006
238
7

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations.
S Galiègue, S Mary, J Marchand, D Dussossoy, D Carrière, P Carayon, M Bouaboula, D Shire, G Le Fur, P Casellas. Eur J Biochem 1995
7

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome.
Orrin Devinsky, J Helen Cross, Linda Laux, Eric Marsh, Ian Miller, Rima Nabbout, Ingrid E Scheffer, Elizabeth A Thiele, Stephen Wright. N Engl J Med 2017
718
7

Phytocannabinoids: a unified critical inventory.
Lumír Ondřej Hanuš, Stefan Martin Meyer, Eduardo Muñoz, Orazio Taglialatela-Scafati, Giovanni Appendino. Nat Prod Rep 2016
313
7

The nonpsychotropic cannabinoid cannabidiol modulates and directly activates alpha-1 and alpha-1-Beta glycine receptor function.
Jörg Ahrens, Reyhan Demir, Martin Leuwer, Jeanne de la Roche, Klaus Krampfl, Nilufar Foadi, Matthias Karst, Gertrud Haeseler. Pharmacology 2009
90
7

The cannabinoid receptor CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55.
Julia Kargl, Nariman Balenga, Gerald P Parzmair, Andrew J Brown, Akos Heinemann, Maria Waldhoer. J Biol Chem 2012
68
10

Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors.
Eva Martínez-Pinilla, Katia Varani, Irene Reyes-Resina, Edgar Angelats, Fabrizio Vincenzi, Carlos Ferreiro-Vera, Julen Oyarzabal, Enric I Canela, José L Lanciego, Xavier Nadal,[...]. Front Pharmacol 2017
100
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.